Podocarpic acid
CAS No. 5947-49-9
Podocarpic acid ( —— )
Catalog No. M26389 CAS No. 5947-49-9
Podocarpic acid is a natural product and a novel TRPA1 activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 53 | Get Quote |
|
25MG | 85 | Get Quote |
|
50MG | 122 | Get Quote |
|
100MG | 178 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePodocarpic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPodocarpic acid is a natural product and a novel TRPA1 activator.
-
DescriptionPodocarpic acid is a natural product and a novel TRPA1 activator. (In Vitro):Podocarpic acid activates SKN-1 in C. elegans, similar to known Nrf2 activators such as α-lipoic acid (LA).(In Vivo):Podocarpic acid and LA alleviate the Podocarpic acidthogenic phenotypes of glod-4 animals by reverting the high endogenous MGO and GO to almost wild-type-like levels.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5947-49-9
-
Formula Weight274.4
-
Molecular FormulaC17H22O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CCc3ccc(O)cc3[C@@]1(C)CCC[C@]2(C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jingjing AN, et al. A composition for treating burn wounds. AU2021101843A4.
molnova catalog
related products
-
Pomalidomide-PEG2-CO...
Pomalidomide-PEG2-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
-
Colesevelam Hydrochl...
Colesevelam Hydrochloride is a bile acid sequestrant with a higher affinity for glycocholic acid in vitro. Colesevelam Hydrochloride inhibits bile acid reabsorption, leading to increased bile acid synthesis and reduces cholesterol levels in patients.
-
SBI-477
SBI-477 is a chemical probe stimulated insulin signaling by deactivating the transcription factor MondoA. SBI-477 coordinately inhibits triacylglyceride (TAG) synthesis and enhances basal glucose uptake in human skeletal myocytes.